Detalhe da pesquisa
1.
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition.
J Pharmacol Exp Ther
; 384(3): 331-342, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241203
2.
High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement.
J Biol Chem
; 291(29): 15243-55, 2016 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226529
3.
Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection.
Antimicrob Agents Chemother
; 60(11): 6498-6509, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27550346
4.
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection.
Antimicrob Agents Chemother
; 60(1): 6-13, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438495
5.
High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma.
Exp Hematol Oncol
; 13(1): 59, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831452
6.
Knocking out CD70 rescues CD70-specific nanoCAR T cells from antigen-induced exhaustion.
Cancer Immunol Res
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874582
7.
Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.
J Infect Dis
; 204(6): 837-44, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849281
8.
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Gastroenterology
; 135(5): 1719-1728.e1, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18718838
9.
Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.
J Virol
; 82(2): 966-73, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17977972
10.
Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
J Virol
; 82(1): 435-50, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17942551
11.
Humoral immune response in acute hepatitis C virus infection.
Clin Infect Dis
; 41(5): 667-75, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16080089
12.
Nanobodies®: new ammunition to battle viruses.
Antiviral Res
; 92(3): 389-407, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21939690
13.
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.
J Virol
; 80(21): 10579-90, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16928753
14.
Host cell responses induced by hepatitis C virus binding.
Hepatology
; 43(6): 1326-36, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16729312
15.
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells.
Blood
; 105(9): 3605-14, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15657184
16.
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.
Vaccine
; 22(23-24): 3080-6, 2004 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297058
17.
Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
J Virol
; 76(3): 1181-93, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11773394
18.
Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection model.
J Gen Virol
; 83(Pt 7): 1673-1678, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12075086
19.
Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.
J Hepatol
; 37(3): 370-9, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12175633
20.
Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
J Virol
; 78(15): 8322-32, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15254204